Literature DB >> 1319079

Adenoid cystic carcinoma of the head and neck: evaluation with MR imaging and clinical-pathologic correlation in 27 patients.

R Sigal1, O Monnet, T de Baere, C Micheau, L G Shapeero, M Julieron, J Bosq, D Vanel, J D Piekarski, B Luboinski.   

Abstract

Twenty-seven adenoid cystic carcinomas (ACCs) of the head and neck in 27 patients were evaluated in a retrospective study based on findings at magnetic resonance (MR) imaging and pathologic and clinical examination. Clinical follow-up was obtained over a mean period of 6.3 years (range of follow-up, 3 months to 17 years); all patients underwent one to seven MR examinations. On T2-weighted images, lesions with low signal intensity corresponded to highly cellular tumors (solid subtype) with a poor prognosis; lesions with high signal intensity corresponded to less cellular tumors (cribriform or tubular subtype) with a better prognosis. MR images were not specific in differentiation of ACCs from other types of tumors; this result underscores the need for biopsy to ensure correct diagnosis. Local, intracranial, osseous, and perineural invasion was depicted, but because of its lack of specificity, MR imaging caused overdiagnosis of tumor extension, particularly perineural spread and bone abnormalities.

Entities:  

Mesh:

Year:  1992        PMID: 1319079     DOI: 10.1148/radiology.184.1.1319079

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  23 in total

1.  Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients.

Authors:  Young Cheol Weon; Sun-Won Park; Hyung-Jin Kim; Han-Sin Jeong; Young-Hyeh Ko; In Suh Park; Sung Tae Kim; Chung Hwan Baek; Young-Ik Son
Journal:  Neuroradiology       Date:  2012-02-04       Impact factor: 2.804

2.  Carcinoma ex pleomorphic adenoma of soft palate with cavernous sinus invasion.

Authors:  Hsuan-Ho Chen; Li-Yu Lee; Shy-Chyi Chin; I-How Chen; Chun-Ta Liao; Shiang-Fu Huang
Journal:  World J Surg Oncol       Date:  2010-03-30       Impact factor: 2.754

3.  Radiologic-pathologic correlation of unusual lingual masses: Part II: benign and malignant tumors.

Authors:  S H Kim; M H Han; S W Park; K H Chang
Journal:  Korean J Radiol       Date:  2001 Jan-Mar       Impact factor: 3.500

Review 4.  Pleomorphic adenoma of salivary glands: common and uncommon CT and MR imaging features.

Authors:  Hiroki Kato; Masaya Kawaguchi; Tomohiro Ando; Keisuke Mizuta; Mitsuhiro Aoki; Masayuki Matsuo
Journal:  Jpn J Radiol       Date:  2018-05-29       Impact factor: 2.374

5.  MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease.

Authors:  A Christe; C Waldherr; R Hallett; P Zbaeren; H Thoeny
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-30       Impact factor: 3.825

6.  Adenoid cystic carcinoma of the skull base.

Authors:  P R Issing; I Hemmanouil; T Stöver; H G Kempf; L Wilkens; R Heermann; T Lenarz
Journal:  Skull Base Surg       Date:  1999

7.  Adenoid cystic carcinoma of the maxillary sinus: CT and MR imaging findings.

Authors:  Hiroki Kato; Masayuki Kanematsu; Kota Sakurai; Keisuke Mizuta; Mitsuhiro Aoki; Yoshinobu Hirose; Shimpei Kawaguchi; Akifumi Fujita; Koshi Ikeda; Tomonori Kanda
Journal:  Jpn J Radiol       Date:  2013-09-21       Impact factor: 2.374

8.  Radiological features of adenoid cystic carcinoma of the uterine cervix.

Authors:  Ayumi Kaku; Hiro Kiyosue; Shunro Matsumoto; Hiromu Mori; Kenji Kashima; Isao Miyakawa
Journal:  Eur Radiol       Date:  2004-10-06       Impact factor: 5.315

Review 9.  CT and MR imaging of the buccal space: normal anatomy and abnormalities.

Authors:  Hyo Cheol Kim; Moon Hee Han; Min Hoan Moon; Ji Hoon Kim; In One Kim; Kee Hyun Chang
Journal:  Korean J Radiol       Date:  2005 Jan-Mar       Impact factor: 3.500

Review 10.  Cancer of the oral cavity and oropharynx.

Authors:  Dechen Wangmo Tshering Vogel; Peter Zbaeren; Harriet C Thoeny
Journal:  Cancer Imaging       Date:  2010-03-16       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.